VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update. “In the first six months of 2026, we have made ...
This week’s Current Climate newsletter also looks at how nuclear startups achieved successful testing to meet a Trump ...
Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...
Parsons is a leading PFAS solutions provider in North America.The company combines science-based strategies, in-house R&D, ...
A team of scientists from Oak Ridge National Laboratory (ORNL), Cleveland Clinic, and IBM (NYSE: IBM), have calculated nine ...
Analysis of hospital samples dating back to the 1970s has revealed how Acinetobacter baumannii—a notoriously stubborn ...
Open access publishing makes scientific research more accessible to researchers, students, and the general public. Discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results